In line with other studies, TREM2 TAMs were highly enriched in tumors but not in adjacent liver tissue and were an indicator of shorter survival in HCC patients [66], suggesting the immunosuppressive role of TREM2 in the liver TME. Here, TREM2 is linked to hepatocellular carcinoma.